VIEWPOINTS


Viewpoints is a collection of opinion articles written by thought leaders and expert medical writers to draw attention to important issues and developments in oncology.


Paclitaxel, Trastuzumab New Standard of Care for Early-Stage Breast Cancer

Paclitaxel, Trastuzumab New Standard of Care for Early-Stage Breast Cancer

Trastuzumab has been approved for nearly a decade, but it is still unclear which women with early-stage disease might benefit most from treatment.

Crizotinib Provides Benefit for ALK-Rearranged NSCLC with Brain Metastases

Crizotinib Provides Benefit for ALK-Rearranged NSCLC with Brain Metastases

A retrospective analysis of crizotinib data demonstrates control in advanced, metastatic disease, although brain metastases continued to progress.

Optimal Prostate Screening Programs Could Significantly Help Lower Mortality

Optimal Prostate Screening Programs Could Significantly Help Lower Mortality

Some researchers are looking at the evidence and urging for a middle ground in prostate cancer screening guidelines

Metformin Does Not Reduce Lung Cancer Risk

Metformin Does Not Reduce Lung Cancer Risk

A large, retrospective cohort study found no evidence that metformin prevents lung cancer, although nonsmokers may find some benefit.

Can Integrated Health Care Eliminate Racial Disparities in Cancer Survival?

Can Integrated Health Care Eliminate Racial Disparities in Cancer Survival?

Racial disparities in colorectal cancer survival might be eliminated by integrated and "equitable, evidence-based care."

Breast Cancer Risk Prediction Models

Breast Cancer Risk Prediction Models

Studies explore the features to assess in a risk model to predict probability of breast cancer in women with benign breast biopsy or African American women.

Updated Guidelines for the Treatment of Thyroid Nodules

Updated Guidelines for the Treatment of Thyroid Nodules

Richard T. Kloos, MD, discusses new technologies and methods for diagnosis of thyroid nodules.

Short-Term Outcomes Comparable Between Active Surveillance, Surgery for Localized Renal Tumors

Short-Term Outcomes Comparable Between Active Surveillance, Surgery for Localized Renal Tumors

Larger renal tumors managed with active surveillance are associated with tumor growth and mortality rates similar to patients treated with surgery.

Breast Cancer Risk: Among Postmenopausal Women, Metabolic Health More Important than Weight

Breast Cancer Risk: Among Postmenopausal Women, Metabolic Health More Important than Weight

In one of the first studies to evaluate the association between insulin and breast cancer, fasting insulin levels may be useful to individualize screening.

Vaccine with Sequential Androgen Ablation Therapy Shows Promise in Prostate Cancer

Vaccine with Sequential Androgen Ablation Therapy Shows Promise in Prostate Cancer

PROSTVAC-VF was found to be well tolerated and 63% of eligible patients were free of PSA, radiographic, and clinical progression.

Black Women Disproportionately Affected by Early-Stage Breast Cancer

Black Women Disproportionately Affected by Early-Stage Breast Cancer

Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.

Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma

Surveillance Until Rituximab Retreatment Does Not Increase Anxiety in Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma relapse is not a cause for increased anxiety if recurrence is quickly addressed with well tolerated therapy.

CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

CancerLinQTM Enrolls Practices, Prepares to Usher in 'Big Data Oncology' Era

ASCO's CancerLinQ go live later this year, ushering in what they described as a transformative era of big data-driven precision cancer care.

ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

ASCO Announces Chronic Leukemia Treatment as Cancer Advance of the Year

The transformation of the treatment of chronic lymphocytic leukemia wins the Society's accolade.

Genetic, Metabolic Factors Are Targets of Research in Renal Cell Carcinoma

Genetic, Metabolic Factors Are Targets of Research in Renal Cell Carcinoma

Recent studies reveal the mechanisms underlying renal cell carcinoma (RCC) and suggest new therapeutic targets.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs